Rezlidhia

Active Ingredient(s): Olutasidenib
FDA Approved: * December 1, 2022
Pharm Company: * RIGEL PHARMS INC
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rezlidhia 150 mg Oral Capsule
NDC: 71332-005
Labeler:
Rigel Pharmaceuticals, Inc.